Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 300

1.

Characterization of Salmonella enterica isolates causing bacteremia in Lima, Peru, using multiple typing methods.

Silva C, Betancor L, García C, Astocondor L, Hinostroza N, Bisio J, Rivera J, Perezgasga L, Pérez Escanda V, Yim L, Jacobs J, García-Del Portillo F; SalmoIber CYTED Network, Chabalgoity JA, Puente JL.

PLoS One. 2017 Dec 21;12(12):e0189946. doi: 10.1371/journal.pone.0189946. eCollection 2017.

2.

Self-Conjugation of the Enteropathogenic Escherichia coli Adherence Factor Plasmid of Four Typical EPEC Isolates.

Silva C, Zavala-Alvarado C, Puente JL.

Biomed Res Int. 2017;2017:6325736. doi: 10.1155/2017/6325736. Epub 2017 Oct 26.

3.

Glycated hemoglobin: A powerful tool not used enough in primary care.

Salinas M, López-Garrigós M, Flores E, Leiva-Salinas C; Pilot Group of the Appropriate Utilization of Laboratory Tests.

J Clin Lab Anal. 2017 Aug 30. doi: 10.1002/jcla.22310. [Epub ahead of print]

PMID:
28857364
4.

Effects of static magnetic fields on the enteropathogenic Escherichia coli.

Quiñones-Peña MA, Tavizon G, Puente JL, Martínez-Anaya C, Hernández-Chiñas U, Eslava CA.

Bioelectromagnetics. 2017 Oct;38(7):570-578. doi: 10.1002/bem.22077. Epub 2017 Aug 25.

PMID:
28840936
5.

Locus of Adhesion and Autoaggregation (LAA), a pathogenicity island present in emerging Shiga Toxin-producing Escherichia coli strains.

Montero DA, Velasco J, Del Canto F, Puente JL, Padola NL, Rasko DA, Farfán M, Salazar JC, Vidal R.

Sci Rep. 2017 Aug 1;7(1):7011. doi: 10.1038/s41598-017-06999-y.

6.

Draft Genome Sequence of Salmonella enterica subsp. enterica Serovar Infantis Strain SPE101, Isolated from a Chronic Human Infection.

Iriarte A, Giner-Lamia J, Silva C, Betancor L, Astocondor L, Cestero JJ, Ochoa T, García C, Puente JL, Chabalgoity JA; SalmoIber CYTED Network, García-Del Portillo F.

Genome Announc. 2017 Jul 20;5(29). pii: e00679-17. doi: 10.1128/genomeA.00679-17.

7.

Salmonella virulence plasmid: pathogenesis and ecology.

Silva C, Puente JL, Calva E.

Pathog Dis. 2017 Jun 22. doi: 10.1093/femspd/ftx070. [Epub ahead of print]

PMID:
28645187
8.

Perspective: The One Health Concept - the Aztec empire and beyond.

Puente JL, Calva E.

Pathog Dis. 2017 Jun 12. doi: 10.1093/femspd/ftx062. [Epub ahead of print] No abstract available.

PMID:
28605517
9.

Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting.

Puente J, Grande E, Medina A, Maroto P, Lainez N, Arranz JA.

Ther Adv Med Oncol. 2017 May;9(5):307-318. doi: 10.1177/1758834017692779. Epub 2017 Mar 1. Review.

10.

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

Conteduca V, Wetterskog D, Sharabiani MTA, Grande E, Fernandez-Perez MP, Jayaram A, Salvi S, Castellano D, Romanel A, Lolli C, Casadio V, Gurioli G, Amadori D, Font A, Vazquez-Estevez S, González Del Alba A, Mellado B, Fernandez-Calvo O, Méndez-Vidal MJ, Climent MA, Duran I, Gallardo E, Rodriguez A, Santander C, Sáez MI, Puente J, Gasi Tandefelt D, Wingate A, Dearnaley D; PREMIERE Collaborators; Spanish Oncology Genitourinary Group, Demichelis F, De Giorgi U, Gonzalez-Billalabeitia E, Attard G.

Ann Oncol. 2017 Jul 1;28(7):1508-1516. doi: 10.1093/annonc/mdx155.

PMID:
28472366
11.

Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.

González Del Alba A, Arranz JÁ, Puente J, Méndez-Vidal MJ, Gallardo E, Grande E, Pérez-Valderrama B, González-Billalabeitia E, Lázaro-Quintela M, Pinto Á, Lainez N, Piulats JM, Esteban E, Maroto Rey JP, García JA, Suárez C.

Crit Rev Oncol Hematol. 2017 May;113:171-190. doi: 10.1016/j.critrevonc.2017.03.010. Epub 2017 Mar 14. Review.

PMID:
28427506
12.

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.

Puente J, Laínez N, Dueñas M, Méndez-Vidal MJ, Esteban E, Castellano D, Martinez-Fernández M, Basterretxea L, Juan-Fita MJ, Antón L, León L, Lambea J, Pérez-Valderrama B, Vázquez S, Suarez C, Del Muro XG, Gallardo E, Maroto JP, Samaniego ML, Suárez-Paniagua B, Sanz J, Paramio JM; SOGUG (Spanish Oncology Genitourinary Group).

Oncotarget. 2017 May 2;8(18):30410-30421. doi: 10.18632/oncotarget.16494.

13.

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.

Rosell R, Dafni U, Felip E, Curioni-Fontecedro A, Gautschi O, Peters S, Massutí B, Palmero R, Aix SP, Carcereny E, Früh M, Pless M, Popat S, Kotsakis A, Cuffe S, Bidoli P, Favaretto A, Froesch P, Reguart N, Puente J, Coate L, Barlesi F, Rauch D, Thomas M, Camps C, Gómez-Codina J, Majem M, Porta R, Shah R, Hanrahan E, Kammler R, Ruepp B, Rabaglio M, Kassapian M, Karachaliou N, Tam R, Shames DS, Molina-Vila MA, Stahel RA; BELIEF collaborative group.

Lancet Respir Med. 2017 May;5(5):435-444. doi: 10.1016/S2213-2600(17)30129-7. Epub 2017 Apr 10.

PMID:
28408243
14.

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.

García-Donas J, Font A, Pérez-Valderrama B, Virizuela JA, Climent MÁ, Hernando-Polo S, Arranz JÁ, Del Mar Llorente M, Lainez N, Villa-Guzmán JC, Mellado B, Del Alba AG, Castellano D, Gallardo E, Anido U, Del Muro XG, Domènech M, Puente J, Morales-Barrera R, Pérez-Gracia JL, Bellmunt J.

Lancet Oncol. 2017 May;18(5):672-681. doi: 10.1016/S1470-2045(17)30242-5. Epub 2017 Apr 4.

PMID:
28389316
15.

IL-22 Controls Iron-Dependent Nutritional Immunity Against Systemic Bacterial Infections.

Sakamoto K, Kim YG, Hara H, Kamada N, Caballero-Flores G, Tolosano E, Soares MP, Puente JL, Inohara N, Núñez G.

Sci Immunol. 2017 Feb;2(8). pii: eaai8371. doi: 10.1126/sciimmunol.aai8371. Epub 2017 Feb 3.

16.

Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.

Salvador J, Aparicio J, Baron FJ, García-Campelo R, Garcia-Carbonero R, Lianes P, Llombart A, Isla D, Piera JM, Muñoz M, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P.

Clin Transl Oncol. 2017 Apr;19(4):525. doi: 10.1007/s12094-017-1628-z. No abstract available.

PMID:
28243989
17.

Primary care requests for anaemia chemistry tests in Spain: potential iron, transferrin and folate over-requesting.

Salinas M, López-Garrigós M, Flores E, Leiva-Salinas C; Pilot Group of the Appropriate Utilization of Laboratory Tests (REDCONLAB) working group.

J Clin Pathol. 2017 Sep;70(9):760-765. doi: 10.1136/jclinpath-2016-204249. Epub 2017 Feb 17.

PMID:
28213561
18.

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators.

N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17.

19.

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

Beer TM, Kwon ED, Drake CG, Fizazi K, Logothetis C, Gravis G, Ganju V, Polikoff J, Saad F, Humanski P, Piulats JM, Gonzalez Mella P, Ng SS, Jaeger D, Parnis FX, Franke FA, Puente J, Carvajal R, Sengeløv L, McHenry MB, Varma A, van den Eertwegh AJ, Gerritsen W.

J Clin Oncol. 2017 Jan;35(1):40-47. Epub 2016 Oct 31.

PMID:
28034081
20.

Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists.

Rivera F, Andres R, Felip E, Garcia-Campelo R, Lianes P, Llombart A, Piera JM, Puente J, Rodriguez CA, Vera R, Virizuela JA, Martin M, Garrido P.

Clin Transl Oncol. 2017 Apr;19(4):508-518. doi: 10.1007/s12094-016-1595-9. Epub 2016 Dec 22. Review.

Supplemental Content

Loading ...
Support Center